CLINICAL_TRIALS
trial_result
· 2014-12-19
Clinical Trial Update: Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis [Phase 3]
Summary
Sanofi reported the results of a Phase III trial comparing teriflunomide to placebo in patients with a first clinical symptom of multiple sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2014-12-19